JP2006514116A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006514116A5 JP2006514116A5 JP2005510345A JP2005510345A JP2006514116A5 JP 2006514116 A5 JP2006514116 A5 JP 2006514116A5 JP 2005510345 A JP2005510345 A JP 2005510345A JP 2005510345 A JP2005510345 A JP 2005510345A JP 2006514116 A5 JP2006514116 A5 JP 2006514116A5
- Authority
- JP
- Japan
- Prior art keywords
- medicament
- prevention
- patient
- item
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000011510 cancer Diseases 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 0 CC(C)C(C(*)NC(C)C)=O Chemical compound CC(C)C(C(*)NC(C)C)=O 0.000 description 3
- WYJOVVXUZNRJQY-UHFFFAOYSA-N CC(c1ccc[s]1)=O Chemical compound CC(c1ccc[s]1)=O WYJOVVXUZNRJQY-UHFFFAOYSA-N 0.000 description 2
- RIFKADJTWUGDOV-UHFFFAOYSA-N CC(C1CCCCC1)=O Chemical compound CC(C1CCCCC1)=O RIFKADJTWUGDOV-UHFFFAOYSA-N 0.000 description 1
- XREBEJBUPRGGTB-UHFFFAOYSA-N CC(CSc1ccccc1)=O Chemical compound CC(CSc1ccccc1)=O XREBEJBUPRGGTB-UHFFFAOYSA-N 0.000 description 1
- WEGYGNROSJDEIW-UHFFFAOYSA-N CC(c1cccnc1)=O Chemical compound CC(c1cccnc1)=O WEGYGNROSJDEIW-UHFFFAOYSA-N 0.000 description 1
- HDNRAPAFJLXKBV-UHFFFAOYSA-N CCc(cc1)ccc1OC Chemical compound CCc(cc1)ccc1OC HDNRAPAFJLXKBV-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42917402P | 2002-11-25 | 2002-11-25 | |
| US47553903P | 2003-06-02 | 2003-06-02 | |
| PCT/US2003/038175 WO2004047771A2 (en) | 2002-11-25 | 2003-11-25 | Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006514116A JP2006514116A (ja) | 2006-04-27 |
| JP2006514116A5 true JP2006514116A5 (US20070167479A1-20070719-C00034.png) | 2007-02-15 |
Family
ID=32397181
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005512876A Pending JP2006515866A (ja) | 2002-11-25 | 2003-11-25 | 腫瘍および内皮細胞を標的とするペプチド、その組成物および使用 |
| JP2005510345A Pending JP2006514116A (ja) | 2002-11-25 | 2003-11-25 | 血管形生、細胞移動、細胞侵入及び細胞増殖を阻害するペプチド、組成物及びそれらの使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005512876A Pending JP2006515866A (ja) | 2002-11-25 | 2003-11-25 | 腫瘍および内皮細胞を標的とするペプチド、その組成物および使用 |
Country Status (14)
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2507045A1 (en) | 2002-11-25 | 2004-06-10 | Attenuon, Llc | Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof |
| JP2007538233A (ja) * | 2004-05-21 | 2007-12-27 | エムディーエス インコーポレイテッド ドゥーイング ビジネス スルー イッツ エムディーエス ファーマ サービシーズ ディビジョン | 医療デバイスの細胞結合特性を定量する方法 |
| US20060078535A1 (en) * | 2004-10-13 | 2006-04-13 | The Regents Of The University Of Michigan | Anticancer compounds and methods |
| EP1843779A2 (en) * | 2005-02-01 | 2007-10-17 | Attenuon, LLC | Compositions containing the anti-angiogenic phscn-peptide |
| WO2006084016A1 (en) | 2005-02-01 | 2006-08-10 | Attenuon, Llc | ACID ADDITION SALTS OF Ac-PHSCN-NH2 |
| AU2016213759B2 (en) * | 2006-11-08 | 2018-03-29 | Chongxi Yu | Transdermal delivery systems of peptides and related compounds |
| CA2668500C (en) * | 2006-11-08 | 2018-07-31 | Chongxi Yu | Transdermal delivery systems of peptides and related compounds |
| KR20180110187A (ko) | 2009-05-08 | 2018-10-08 | 테크필즈 바이오켐 코., 엘티디. | 펩티드 및 펩티드관련 화합물의 고침투성 전구약물 조성물 |
| KR101228668B1 (ko) | 2010-09-17 | 2013-01-31 | 가톨릭대학교 산학협력단 | 혈관신생 억제 활성을 갖는 펩타이드 및 이의 용도 |
| GB2510488B (en) | 2011-06-23 | 2020-04-08 | Univ Texas | Identifying peptides at the single molecule level |
| US11435358B2 (en) | 2011-06-23 | 2022-09-06 | Board Of Regents, The University Of Texas System | Single molecule peptide sequencing |
| CN102417540A (zh) * | 2011-11-21 | 2012-04-18 | 中国药科大学 | 一种聚乙二醇修饰的整合素阻断剂hm-3及其应用 |
| WO2013170195A1 (en) * | 2012-05-11 | 2013-11-14 | Medicus Biosciences, Llc | Biocompatible hydrogel treatments for retinal detachment |
| EP2967056B1 (en) | 2013-03-15 | 2018-02-21 | Suncor Energy Inc. | Herbicidal compositions |
| JP5970439B2 (ja) * | 2013-09-20 | 2016-08-17 | チョンシー ユー | ペプチド及び関連化合物の経皮送達システム |
| US10545153B2 (en) | 2014-09-15 | 2020-01-28 | Board Of Regents, The University Of Texas System | Single molecule peptide sequencing |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3845770A (en) * | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US3916899A (en) * | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
| US4440788A (en) * | 1980-05-13 | 1984-04-03 | Mitsubishi Chemical Industries, Limited | Cysteine derivatives |
| EP0051682B1 (en) * | 1980-05-13 | 1984-09-05 | Mitsubishi Kasei Corporation | Cysteine derivatives and process for their preparation |
| US4394519A (en) * | 1982-01-19 | 1983-07-19 | Research Corporation | Amino acid blocking agents |
| GB8504253D0 (en) | 1985-02-19 | 1985-03-20 | Ici Plc | Electrostatic spraying apparatus |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| DE3815221C2 (de) * | 1988-05-04 | 1995-06-29 | Gradinger F Hermes Pharma | Verwendung einer Retinol- und/oder Retinsäureester enthaltenden pharmazeutischen Zubereitung zur Inhalation zur Einwirkung auf die Schleimhäute des Tracheo-Bronchialtraktes einschließlich der Lungenalveolen |
| US5091176A (en) * | 1988-11-02 | 1992-02-25 | W. R. Grace & Co.-Conn. | Polymer-modified peptide drugs having enhanced biological and pharmacological activities |
| US5443816A (en) * | 1990-08-08 | 1995-08-22 | Rhomed Incorporated | Peptide-metal ion pharmaceutical preparation and method |
| US5229366A (en) * | 1990-10-23 | 1993-07-20 | Fuji Photo Film Co., Ltd. | Peptide-containing polyethylene glycol derivatives and application thereof |
| US5149801A (en) * | 1990-11-21 | 1992-09-22 | The Regents Of The University Of California | Boronated porphyrin compounds |
| US5561220A (en) | 1991-02-08 | 1996-10-01 | Diatech, Inc. | Technetium-99m labeled peptides for imaging inflammation |
| US5698155A (en) * | 1991-05-31 | 1997-12-16 | Gs Technologies, Inc. | Method for the manufacture of pharmaceutical cellulose capsules |
| US5556609A (en) * | 1992-02-20 | 1996-09-17 | Rhomed Incorporated | YIGSR peptide radiopharmaceutical applications |
| US5608110A (en) | 1993-06-15 | 1997-03-04 | Bracco International B.V. | Heteroatom-bearing ligands and metal complexes thereof |
| US5639725A (en) * | 1994-04-26 | 1997-06-17 | Children's Hospital Medical Center Corp. | Angiostatin protein |
| ZA962078B (en) | 1995-03-14 | 1996-09-25 | Siemens Ag | Ultrasonic atomizer device with removable precision dosating unit |
| ATE218381T1 (de) * | 1995-03-14 | 2002-06-15 | Siemens Ag | Ultraschall-zerstäuber mit abnehmbarer präzisionsdosiereinheit |
| US5618513A (en) * | 1995-06-07 | 1997-04-08 | Mallinckrodt Medical, Inc. | Method for preparing radiolabeled peptides |
| MY147327A (en) * | 1995-06-29 | 2012-11-30 | Novartis Ag | Somatostatin peptides |
| JP2001501600A (ja) * | 1996-09-10 | 2001-02-06 | ザ バーナム インスティテュート | 腫瘍ホーミング分子、それに由来する結合体、およびその使用方法 |
| US6025150A (en) * | 1996-11-21 | 2000-02-15 | The Regents Of The University Of Michigan | Methods and compositions for wound healing |
| US6001965A (en) * | 1996-11-21 | 1999-12-14 | The Regents Of The University Of Michigan | Anticancer compounds and methods |
| US6331409B1 (en) * | 1996-11-21 | 2001-12-18 | The Regents Of The University Of Michigan | Methods and compositions for wound healing |
| DE69824352T2 (de) * | 1997-01-14 | 2005-06-30 | Kaneka Corp. | Verfahren zur herstellung von cystein derivaten |
| US5994309A (en) * | 1997-07-25 | 1999-11-30 | Angstrom Pharmaceuticals, Inc. | Anti-invasive and anti-angiogenic compositions and methods |
| JP2001516055A (ja) * | 1997-09-10 | 2001-09-25 | ザ バーナム インスティチュート | 腫瘍中の血管形成血管系にホーミングする分子を同定する方法 |
| NZ504021A (en) * | 1997-10-17 | 2003-04-29 | Systemic Pulmonary Delivery Lt | Method and apparatus for delivering aerosolized medication having air discharged through air tube directly into plume of aerosolized medication |
| US6468974B1 (en) * | 1998-08-14 | 2002-10-22 | The Administrators Of The Tulane Educational Fund | Compounds having growth hormone releasing activity |
| ATE366936T1 (de) | 2001-01-18 | 2007-08-15 | Univ Michigan | Zusammensetzungen und verfahren zur verwendung von fibronektin-fragmenten bei krebsdiagnose |
| CA2507045A1 (en) * | 2002-11-25 | 2004-06-10 | Attenuon, Llc | Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof |
-
2003
- 2003-11-25 CA CA002507045A patent/CA2507045A1/en not_active Abandoned
- 2003-11-25 EA EA200500871A patent/EA200500871A1/ru unknown
- 2003-11-25 US US10/723,144 patent/US7517855B2/en not_active Expired - Fee Related
- 2003-11-25 KR KR1020057009447A patent/KR20050097494A/ko not_active Application Discontinuation
- 2003-11-25 EP EP03796483A patent/EP1569678A4/en not_active Withdrawn
- 2003-11-25 JP JP2005512876A patent/JP2006515866A/ja active Pending
- 2003-11-25 BR BR0316523-0A patent/BR0316523A/pt not_active IP Right Cessation
- 2003-11-25 WO PCT/US2003/037895 patent/WO2004063213A2/en not_active Application Discontinuation
- 2003-11-25 NZ NZ540889A patent/NZ540889A/en not_active IP Right Cessation
- 2003-11-25 US US10/722,843 patent/US20050020810A1/en not_active Abandoned
- 2003-11-25 MX MXPA05005469A patent/MXPA05005469A/es not_active Application Discontinuation
- 2003-11-25 AU AU2003298726A patent/AU2003298726A1/en not_active Abandoned
- 2003-11-25 EA EA200500870A patent/EA200500870A1/ru unknown
- 2003-11-25 PL PL377701A patent/PL377701A1/pl not_active Application Discontinuation
- 2003-11-25 CA CA002506813A patent/CA2506813A1/en not_active Abandoned
- 2003-11-25 WO PCT/US2003/038175 patent/WO2004047771A2/en not_active Application Discontinuation
- 2003-11-25 KR KR1020057009356A patent/KR20050096917A/ko not_active Application Discontinuation
- 2003-11-25 NZ NZ540363A patent/NZ540363A/en unknown
- 2003-11-25 BR BR0316550-7A patent/BR0316550A/pt not_active IP Right Cessation
- 2003-11-25 PL PL377763A patent/PL377763A1/pl not_active Application Discontinuation
- 2003-11-25 EP EP03812058A patent/EP1594521A4/en not_active Withdrawn
- 2003-11-25 AU AU2003297609A patent/AU2003297609A1/en not_active Abandoned
- 2003-11-25 MX MXPA05005545A patent/MXPA05005545A/es unknown
- 2003-11-25 JP JP2005510345A patent/JP2006514116A/ja active Pending
-
2005
- 2005-06-21 HR HR20050585A patent/HRP20050585A2/xx not_active Application Discontinuation
- 2005-06-21 HR HR20050584A patent/HRP20050584A2/hr not_active Application Discontinuation
- 2005-06-24 NO NO20053111A patent/NO20053111L/no not_active Application Discontinuation
- 2005-06-24 NO NO20053112A patent/NO20053112L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006514116A5 (US20070167479A1-20070719-C00034.png) | ||
| JP2005500357A5 (US20070167479A1-20070719-C00034.png) | ||
| JP2003503454A5 (US20070167479A1-20070719-C00034.png) | ||
| HK1214253A1 (zh) | -噁二唑苯甲酸化合物及其在無義抑制和疾病治療中的用途 | |
| ZA200802897B (en) | New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of Alzheimer's Disease | |
| JP2006502236A5 (US20070167479A1-20070719-C00034.png) | ||
| WO2004062604A3 (en) | Treatment of cancer with 2-deoxyglucose | |
| IL170120A (en) | 4,2,1 - Triazines, their use in the preparation of HIV treatment or prophylaxis drugs, containing pharmaceutical preparations and methods for their preparation | |
| JP2010522242A5 (US20070167479A1-20070719-C00034.png) | ||
| WO2007062093A3 (en) | Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor | |
| HK1080447B (zh) | 視黃醇衍生物、它們在治療癌症和增强其它細胞毒性劑功效中的應用 | |
| EP1848418A4 (en) | USE OF NORDIHYDROGUAIARETIC ACID DERIVATIVES FOR THE TREATMENT OF DRUG RESISTANT VIRAL AND MICROBIAL CANCERS AND INFECTIONS | |
| JP2005507892A5 (US20070167479A1-20070719-C00034.png) | ||
| ZA200203156B (en) | Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrindependent microcirculation disorders. | |
| JP2008513426A5 (US20070167479A1-20070719-C00034.png) | ||
| GB2368525B (en) | Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease | |
| JP2008513427A5 (US20070167479A1-20070719-C00034.png) | ||
| HK1085373A1 (en) | Compound and use in the manufacture of a medicament for the treatment of benign prostatic hyperplasia and associated symptoms | |
| JP2005530735A5 (US20070167479A1-20070719-C00034.png) | ||
| MXPA03006776A (es) | Uso de inhibidores de interleucina-18 para el tratamiento y/o prevencion de enfermedad cardiaca. | |
| JP2005507888A5 (US20070167479A1-20070719-C00034.png) | ||
| SI1545710T1 (sl) | Uporaba N-(3-metoksi-5-metilpirazin-2-il)-2-(4-(1,3,4-oksadiazol-2-il)fenil) piridin-3-sulfonamida v zdravljenju raka | |
| WO2006124573A3 (en) | Treatment of cancer with 2-deoxyglucose | |
| IL162941A0 (en) | Carboxamidine derivatives and their use in the treatment of vascular diseases | |
| JP2005505605A5 (US20070167479A1-20070719-C00034.png) |
